Jointly provided by Dannemiller and Pharmacy Times Continuing Education.
Treating Acute Strains and Sprains in the Convenient Care Clinic
Kimberly J. Henderson, MD, JD
Regional Medical Director, MinuteClinic
Medical Director, Health Service Alliance CVS Health
Woonsocket, Rhode Island
Attending Physician, Department of Emergency Medicine
Mount Sinai Beth Israel Medical Center
New York, New York
Cynthia Borda, PharmD, MBA
Distance Degrees and Programs Office
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Pharmacy Times Office of CPE
Plainsboro, New Jersey
On completion of this activity, the participant will be able to:
Statement of Need
Review the signs and symptoms of the acute sprain and strain
Review the latest medical recommendations for treating strains and sprains
Recall the potential issues involving pain medication and the individual state legislation for nurse practitioners or physician assistants
As the popularity of convenient care clinics increases, so do the types of acute and chronic conditions being seen at these sites. This activity will be looking into treatments of acute sprains and strains by health care professionals other than a medical doctor. A sprain is usually caused by injury to a joint and the ligaments become stretched or torn; a strain is trauma to the muscle or tendon which either becomes stretched or torn. With their different presentations, it is essential for health care professionals to both recognize the signs and symptoms and be knowledgeable of the latest medical recommendations for treating strains and sprains. Additionally, it is important to review potential issues that come with pain medication and to be aware of the individual state legislation for nurse practitioners and physician assistants.
This activity is intended for advanced practice nurses, nurse practitioners and physician assistants working in convenient care clinics.
December 7, 2015
: December 7, 2016
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Dannemiller and PTCE. Dannemiller is accredited by ACCME to provide continuing medical education for physicians.
Dannemiller designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)TM
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)TM
from organizations accredited by ACCME.
Dannemiller is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners: AANP Provider Number 090419.
This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards. It provides 1.0 contact hour(s) of continuing education, which includes 0.5 hour(s) of pharmacology.
Method of Participation
To receive credit, all participants will need to read the objectives and other introductory CME/CE information, take the pretest, and then proceed to the educational activity. Once the activity is completed along with the posttest and the evaluation, participants can request credit.
You will have access to your certificate immediately following completion of the evaluation. Credit is provided until 12/7/2016. No credit will be given after this date. There is no fee to participate in this activity.
In the event you have questions about this activity or are unable to retrieve the certificate, please e-mail email@example.com and a certificate will be emailed within 2 weeks.
System Requirements for Completion of Posttest and Evaluation
Computer or smart phone with Internet access
In accordance with the Accreditation Council for Continuing Medical Education (ACCME), Dannemiller requires that any person who is in a position to control the content of a CME/CE activity must disclose all financial relationships they have with a commercial interest.
The following individuals, who are associated with the planning and execution of this activity, have stated they have no financial relationships with commercial interests:
Kimberly J. Henderson, MD, JD
Cynthia Borda, PharmD, MBA
- Katie Eder
Pharmacy Times Continuing Education
- Dave Heckard, Maryjo Dixon, RPh, Jim Palatine, MBA, RPh, and Tara DeLorenzo
- Gordon Ringler, Myra Garcia
To resolve identified/potential conflicts of interest, the educational content was fully reviewed by a member of the Dannemiller Clinical Content Review Committee, Bernard Abrams, MD, who has nothing to disclose. The resulting certified activity was found to provide educational content that is current, evidence-based, and commercially-balanced.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Dannemiller or Pharmacy Times Continuing Education. This material is prepared based on a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials on the subject.